Diminished activation of excitatory neurons in the prelimbic cortex leads to impaired working memory capacity in mice

Background Working memory capacity impairment is an early sign of Alzheimer's disease, but the underlying mechanisms remain unclear.

Clarifying how working memory capacity is affected will help us better understand the pathological mechanism of Alzheimer's disease.

We used the olfactory working memory capacity paradigm to evaluate memory capacity in 3-month-old 5XFAD (an animal model of Alzheimer's disease) mice.

Immunofluorescence staining of the prefrontal cortex was performed to detect the number of FOS-positive neurons, calmodulin-dependent protein kinase II-positive neurons, and glutamate decarboxylase-positive neurons in the prelimbic cortex and infralimbic cortex.

A chemogenetic method was then used to modulate the inhibition and activation of excitatory neurons in the prelimbic cortex of wild-type and 5XFAD mice and to measure the memory capacity of mice.

Results Working memory capacity was significantly diminished in 5XFAD mice compared to littermate wild-type mice.

Neuronal activation of the prelimbic cortex, but not the infralimbic cortex, was attenuated in 5XFAD mice performing the olfactory working memory capacity task.

Subsequently, the FOS-positive neurons were co-localized with both calmodulin-dependent protein kinase II-positive neurons and glutamate decarboxylase-positive neurons.

The results showed that the activation of excitatory neurons in the prelimbic cortex was correlated with working memory capacity in mice.

Our results further demonstrate that the chemogenetic inhibition of prelimbic cortex excitatory neurons resulted in reduced working memory capacity in wild-type mice, while the chemogenetic activation of prelimbic cortex excitatory neurons improved the working memory capacity of 5XFAD mice.

Conclusion The diminished activation of prelimbic cortex excitatory neurons in 5XFAD mice during task performance is associated with reduced working memory capacity, and activation modulation of excitatory neurons by chemogenetic methods can improve memory capacity impairment in 5XFAD mice.

These findings may provide a new direction for exploring Alzheimer's disease therapeutic approaches.